share_log

HC Wainwright & Co. Maintains Buy on Kiora Pharmaceuticals, Raises Price Target to $3.5

HC Wainwright & Co. Maintains Buy on Kiora Pharmaceuticals, Raises Price Target to $3.5

HC Wainwright & Co.維持對Kiora Pharmicals的買入,將目標股價提高至3.5美元
Benzinga ·  2023/11/06 06:42

HC Wainwright & Co. analyst Yi Chen maintains Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and raises the price target from $2 to $3.5.

HC Wainwright & Co. 分析師陳毅維持Kiora Pharmicals(納斯達克股票代碼:KPRX)的買入,並將目標股價從2美元上調至3.5美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論